Game-changing cancer therapy: Imugene’s VAXINIA receives FDA orphan drug status for bile tract cancer

Imugene Limited has received a significant boost with the United States Food and Drug Administration (FDA) granting Orphan Drug Designation (ODD) to its experimental therapy, ... Read More